Xilio Therapeutics, Inc. (XLO): Price and Financial Metrics
XLO Price/Volume Stats
Current price | $1.04 | 52-week high | $2.04 |
Prev. close | $1.29 | 52-week low | $0.49 |
Day low | $0.90 | Volume | 1,217,972 |
Day high | $1.29 | Avg. volume | 541,067 |
50-day MA | $0.88 | Dividend yield | N/A |
200-day MA | $0.92 | Market Cap | 45.71M |
XLO Stock Price Chart Interactive Chart >
Xilio Therapeutics, Inc. (XLO) Company Bio
Xilio Therapeutics, Inc., a biotechnology company, designs immunotherapies to improve the immune system for cancer patients. Its checkpoint inhibitor programs include XTX101, is a clinical-stage, tumor-selective anti-CTLA-4 mAb that is in Phase 1 clinical trials in patients with solid tumors; and cytokine programs comprise XTX202, XTX301, and XTX401, which are modified form of IL-2 that is masked with a protein domain to prevent binding activity until cleaved off by tumor microenvironment (TME)-associated proteases. Xilio Therapeutics, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
XLO Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | N/A |
5-year | N/A |
YTD | N/A |
2023 | N/A |
2022 | N/A |
2021 | N/A |
2020 | N/A |
2019 | N/A |
Loading social stream, please wait...